iShares Evolved U.S. Innovative Healthcare ETF (IEIH) Research
The iShares Evolved U.S. Innovative Healthcare ETF (IEIH) primarily allocates its capital to the equity securities of U.S.-based pharmaceutical and biotechnology companies. Under typical market conditions, a minimum of 80% of the fund's net assets will be invested in the common stocks of firms across various market capitalizations, including large, mid, and small-cap companies. The ETF also targets enterprises categorized within the "Innovative Healthcare Evolved Sector" — specifically, those whose financial profiles have historically aligned with conventional pharmaceutical and biotechnology businesses. It is important to note that this fund operates as a non-diversified investment vehicle.
Market snapshot
- Symbol
- IEIH
- Price
- $34.13
- Day change
- -0.00%
- Market cap
- $36.8M
- 52-week range
- 34.1-34.1348
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- Abacus FCF International Leaders ETF (ABLG)
- Callaway Golf Company (CALY)
- Global X Telemedicine & Digital Health ETF (EDOC)
- iShares Evolved U.S. Healthcare Staples ETF (IEHS)
- Invesco RAFI Strategic US Small Company ETF (IUSS)
- IQ U.S. Real Estate Small Cap ETF (ROOF)
- Invesco S&P Financials Revenue ETF (RWW)
- AlphaMark Actively Managed Small Cap ETF (SMCP)
Open iShares Evolved U.S. Innovative Healthcare ETF (IEIH) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.